Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Degree

Medical Specialty

Submit

Strategies for Optimal HIV Treatment and Prevention: Answering the Questions on Considering an ART Switch During Pregnancy

Source: Strategies for Optimal HIV Treatment and Prevention

Hear from expert faculty as they answer questions and discuss key considerations when determining whether and how to switch antiretroviral therapy in pregnant people with HIV.

Annette Haberl, MD

William R. Short, MD, MPH, AAHIVS

Released: November 23, 2022

Information on this Educational Activity

Faculty

Annette Haberl, MD

Physician
Head of HIV and Women, HIVCENTER Frankfurt
Department of Infectious Diseases
Hospital of the Johann Wolfgang Goethe-University
Frankfurt, Germany

Annette Haberl, MD: consultant/advisor/speaker: Gilead Sciences, Janssen-Cilag, Merck Sharpe and Dohme, ViiV Healthcare.

William R. Short, MD, MPH, AAHIVS

Associate Professor of Medicine
Division of Infectious Diseases
Department of Medicine
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania

William R. Short, MD, MPH, AAHIVS: non-CME/CE services: Janssen; consultant/advisor/speaker: ViiV.

Program Medium

This program has been made available online.

Welcome to the CCO Site

Strategies for Optimal HIV Treatment and Prevention: Answering the Questions on Considering an ART Switch During Pregnancy

Information on this Educational Activity

Faculty

Program Medium

Leaving the CCO site